Full Breakdown
Trump Announces Major Overhaul of IVF Drug Pricing
10/17/2025, 11:37:13 AM
Core Event: Cost Reduction in IVF Treatments
President Donald Trump has announced a significant reduction in the cost of in-vitro fertilization (IVF) medications, aimed at making fertility treatments more affordable for millions of Americans. During a press conference in the Oval Office, Trump revealed that his administration has reached an agreement with EMD Serono, the U.S. arm of the German drugmaker Merck, to cut the prices of key IVF drugs by up to 84 percent. This initiative is part of a broader effort to enhance access to fertility care, which currently affects nearly 10 million women in the United States struggling to conceive.
Details of the Agreement
The agreement will lower the cost of three major IVF drugs: Gonal-f, Ovidrel, and Cetrotide. Trump stated that the per-cycle cost of drugs used in IVF would decrease by an estimated 73 percent for consumers, with further reductions expected over time. The average cost for one cycle of IVF is approximately $25,000, making it financially inaccessible for many couples. Under the new deal, medications will be sold directly to consumers at lower prices via the federal website TrumpRx.
Background & Context: Legal Influences on IVF Policy
Trump's focus on reducing IVF costs was influenced by a 2024 ruling from the Alabama Supreme Court, which classified frozen embryos as children under state law. This decision temporarily halted IVF services in Alabama and sparked a political controversy, particularly in light of the 2022 U.S. Supreme Court ruling that overturned Roe v. Wade. Trump noted that Senator Katie Britt, R-Ala., brought this issue to his attention, prompting his administration to take action on IVF affordability.
Official Statements & Responses
In his announcement, Trump emphasized the positive implications of the cost reductions, stating, "We’ll dramatically slash the cost of IVF and the treatment and many of the most common fertility drugs for countless millions of Americans." He also expressed that these actions would lead to healthier pregnancies and more children. The administration has previously negotiated similar deals with pharmaceutical companies Pfizer and AstraZeneca to lower drug prices for Medicaid.
Criticism & Opposition
Despite the positive reception from some quarters, there are dissenting views regarding Trump's support for IVF, particularly from conservative groups who oppose it on religious grounds. When asked about this opposition, Trump remarked, "I think this is very pro-life," indicating his belief that making IVF more accessible aligns with pro-life values.
Verbatim Quotes
- “The president said: 'We’ll dramatically slash the cost of IVF and the treatment and many of the most common fertility drugs for countless millions of Americans.” — President Donald Trump
- “You can’t get more pro-life than this.” — President Donald Trump
What's Next: Future Implications
The administration's initiative to reduce IVF costs is expected to have significant implications for fertility treatments in the U.S. As the FDA works with EMD Serono to expedite the approval of additional fertility drugs, the landscape of reproductive health care may continue to evolve, potentially increasing access and affordability for couples seeking assistance in conceiving.
